ACTILYSE

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug ACTILYSE contains one active pharmaceutical ingredient (API):

1
UNII 1RXS4UE564 - ALTEPLASE
 

Alteplase is a recombinant human tissue-type plasminogen activator, a glycoprotein, which activates plasminogen directly to plasmin. Once bound to fibrin, it is activated, inducing the conversion of plasminogen to plasmin leading to the dissolution of the fibrin clot.

 
Read more about Alteplase

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ACTILYSE Powder and solvent for solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B01AD02 Alteplase B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AD Enzymes
Discover more medicines within B01AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 504500101153319, 504512030018303, 504512030018403
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 29776-05-11
EE Ravimiamet 1004128, 1700109, 1885383
ES Centro de información online de medicamentos de la AEMPS 59494
FI Lääkealan turvallisuus- ja kehittämiskeskus 387675, 404491, 404533
FR Base de données publique des médicaments 63617876, 67177673
GB Medicines & Healthcare Products Regulatory Agency 344939, 48386, 48398, 48453
HK Department of Health Drug Office 30511, 37894
HR Agencija za lijekove i medicinske proizvode HR-H-191255719, HR-H-676368257
IL מִשְׂרַד הַבְּרִיאוּת 7364, 7365
LT Valstybinė vaistų kontrolės tarnyba 1007453, 1061418, 1061419
MT Medicines Authority MA211/00901, MA211/00902, MA211/00903
NL Z-Index G-Standaard 13250949, 13733370
NL Z-Index G-Standaard, PRK 25747, 36870
NZ Medicines and Medical Devices Safety Authority 13161, 4765, 4766, 4767
PL Rejestru Produktów Leczniczych 100002579, 100002585, 100002622
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W00257001
SG Health Sciences Authority 02340P
TN Direction de la Pharmacie et du Médicament 5253111H, 5253112H, 5253113H
TR İlaç ve Tıbbi Cihaz Kurumu 8699693790026, 8699693790033, 8699693790040
ZA Health Products Regulatory Authority U/31/229

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.